Delivra Health Brands Inc. experienced a remarkable surge, closing up 30% in yesterday's trading session.
Delivra Health Brands Inc. (DHB.V) saw its stock price rise significantly yesterday, closing at CA$0.13. This 30% increase marks a notable performance for the company, which operates in the health and wellness sector.
Advertisement
Delivra Health Brands Inc.
DHB.V
DHB.V
Delivra Health Brands Inc.
WealthAwesomeMarket cap
$4.06M
52W high
$0.37
52W low
$0.09
1W change
+8.33%
Beta
0.89
Analyst Price Targets
Based on analyst covering DHB
Wall Street analysts forecast DHB stock price to rise 307.7% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.53
+307.7% Upside
Current Price
C$0.13
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on DHB's historical volatility
30-Day Vol
139.3%
Annualized
90-Day Vol
126.0%
Annualized
Trend (90d)
-0.0%
Annualized drift
90d Mean
C$0.13
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.13 | C$0.08 – C$0.21 |
| 60 trading days | C$0.13 | C$0.07 – C$0.26 |
| 90 trading days | C$0.13 | C$0.06 – C$0.30 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: The strong performance of Delivra Health Brands indicates positive market sentiment, potentially driven by recent product launches and strategic initiatives.
Delivra Health Brands Inc. stock soared 30% yesterday.
With a market cap of CA$4.06 million, Delivra's stock movement reflects significant volatility typical of small-cap companies.
Bull case
Investors might feel optimistic about Delivra's recent product introductions, like the LivRelief™ Itch Relief Cream. This product could boost its market presence and revenue, tapping into the growing demand for natural health solutions.
Bear case
Despite the surge, Delivra's financials show a negative profit margin, which highlights ongoing challenges that could impact long-term growth.
Advertisement
Market Reaction to Product Launches
Delivra's recent introduction of LivRelief™ Itch Relief Cream may have played a crucial role in boosting investor confidence. The product's entry into the Canadian market aligns with increasing consumer demand for natural health solutions, which could drive sales and enhance brand visibility.
Financial Health and Future Prospects
While the stock surged, Delivra Health Brands Inc. still faces challenges, including a negative profit margin. Investors should weigh the potential for growth against the backdrop of financial instability as the company navigates its strategic initiatives and market expansion.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
